Condensed Statements of Cash Flows (Unaudited) - USD ($)	6 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
Cash Flows from Operating Activities
Net loss	$ (4,700,396)	$ (7,373,838)
Adjustments to reconcile net loss to net cash and cash equivalents from operating activities:
Depreciation and amortization	441,849	339,953
Stock compensation expense	811,611	429,488
Amortization of debt costs		182,900
Interest expense on notes payable converted to common stock		3,430,931
Value of common stock issued in exchange for consulting services	22,698	789,600
Changes in operating assets and liabilities which (used) provided cash:
Accounts receivable	34,525	55,680
Prepaid expenses and other assets	(478,162)	(894,959)
Accounts payable	138,615	(38,759)
Accrued compensation	(129,398)
Deferred revenue	59,368	359,529
Accrued and other liabilities	(13,631)	(29,282)
Net cash and cash equivalents used in operating activities	(3,812,921)	(2,748,757)
Cash Flows from Investing Activities
Purchase of property and equipment	(8,803)	(46,749)
Investment in capitalized software	(500,624)	(406,776)
Net cash and cash equivalents used in investing activities	(509,427)	(453,525)
Cash Flows from Financing Activities – Issuance of common stock – net of issuance costs	1,360,000	12,796,230
Net (Decrease) Increase in Cash and Cash Equivalents	(2,962,348)	9,593,948
Cash and Cash Equivalents - Beginning of period	10,713,091	4,093,874
Cash and Cash Equivalents - End of period	7,750,743	13,687,822
Significant Noncash Transactions:
Acquisition of capitalized software included in accounts payable and accrued liabilities	53,340	56,285
Conversion of convertible notes payable, including accrued interest of $73,315, into 1,127,872 of common stock		2,255,745
Issuance of common stock in exchange for consulting services	$ 22,698	$ 789,600